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Electrocardiographic Precordial ST-Segment Deviations and the Risk
of Cardiovascular Death: Results From the Copenhagen ECG Study
Peter Vibe Rasmussen, BSc; Jonas Bille Nielsen, MD; Adrian Pietersen, MD; Claus Graff, MSc, PhD; Bent Lind, MD, DMSci;
Johannes Jan Struijk, MSc, PhD; Morten Salling Olesen, MSc, PhD; Stig Haunsø, MD, DMSci; Lars Køber, MD, DMSci;
Jesper Hastrup Svendsen, MD, DMSci; Anders Gaarsdal Holst, MD, PhD
Background-—We sought to perform a study assessing the association between electrocardiographic ST-segment deviations and
cardiovascular death (CVD), in relation to sex and age (≥ and <65 years), in a large primary care population without overt ischemic
heart disease.
Methods and Results-—Using computerized analysis of ECGs from 285 194 persons, we evaluated the association between
precordial ST-segment deviations and the risk of CVD. All data on medication, comorbidity, and outcomes were retrieved from
Danish registries. After a median follow-up period of 5.8 years, there were 6679 cardiovascular deaths. Increasing ST-depression
was associated with an increased risk of CVD in almost all of the precordial leads, with the most robust association seen in lead V5
to V6. ST-elevations in lead V2 to V6 were associated with increased risk of CVD in young women, but not in men. However, ST-
elevations in V1 increased the risk for both genders and age groups, exempliﬁed by a HR of 1.80 (95% CI [1.19 to 2.74], P=0.005)
for men <65 years with ST-elevations ≥150 lV versus a nondeviating ST-segment (50 lV to +50 lV). In contrast, for men
<65 years, ST-elevations in lead V2 to V3 conferred a decreased risk of CVD with a HR of 0.77 (95% CI [0.62 to 0.96], P<0.001) for
ST-elevations ≥150 lV in V2.
Conclusion-—We found that ST-depressions were associated with a dose-responsive increased risk of CVD in nearly all the
precordial leads. ST-elevations conferred an increased risk of CVD in women and with regard to lead V1 also in men. However, ST-
elevations in V2 to V3 were associated with a decreased risk of CVD in young men. ( J Am Heart Assoc. 2014;3:e000549 doi:
10.1161/JAHA.113.000549)
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S T-segment deviations in the standard surface electrocar-diogram (ECG) are a common ﬁnding. The electrocardio-
graphic ST-segment reﬂects the depolarized state and initial
repolarization of the ventricles and several factors are known
to affect the ST-segment including acute ischemic disease,
ventricular hypertrophy, electrolytes, various medications,
gender, and age.
ST-depression in the lateral precordial leads (V5 to V6) has
previously been associated with increased mortality in a wide
variety of populations.1–5 Such ST-depressions often appear
as a strain pattern with inverted T-waves thought to result
from subendocardial ischemia or as a consequence of an
increased ventricular workload.6
The case of ST-elevation in the precordial leads is more
complex in its origin and implications. Right and antero-septal
precordial ST-elevations has been described as a normal
variant in young males7,8 but is also associated with
potentially arrythmogenic conditions such as Brugada and
early repolarization syndromes.9
We sought to investigate the spectrum and prevalence of
precordial ST-segment deviations and their relation to age and
gender in a large contemporary primary care population.
Additionally, we aimed to investigate the association between
various degrees of precordial ST-deviations and the risk of
cardiovascular death (CVD). We believe that such knowledge
could lead to a better pathophysiological understanding
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of the nature of ST-deviations and potentially improve risk
stratiﬁcation of patients undergoing standard cardiovascular
evaluation.
Methods
Study Population
In the greater region of Copenhagen, Denmark, the vast
majority of general practitioners refer their patients to one
core facility (CGPL; Copenhagen General Practitioners’ Lab-
oratory) for clinical tests, such as biochemistry and electro-
cardiogram (ECG) recordings. The present study population is
part of the Copenhagen ECG study and consists of all
individuals who had an ECG recorded at CGPL from 2001 to
2011.10,11 We excluded individuals <15 and >90 years of age,
individuals who were in treatment with digoxin on the day of
ECG recording, individuals with a history of ischemic heart
disease at baseline, or with ECG abnormalities inconsistent
with ST-segment assessment (see Electrocardiography). Fur-
ther details on the study population have been described
previously.10–12
In addition, in order to compare the ECG study population
with the general population with respect to incidence rate of
CVD, we randomly sampled individuals from the entire Danish
population (5.6 million), matched 1:2 based on gender, age,
and without ischemic heart disease at the time of inclusion.
Because our study was registry based with no active
participation from study subjects, no approval from an ethics
committee was required according to Danish law. The use of
registry data was approved by the Danish Data Protection
Agency.
Electrocardiography
All ECGs were digitally recorded and stored in the MUSE
Cardiology Information System (GE Healthcare) and were later
processed using version 21 of the Marquette 12SL algorithm.
With the use of 12SL statements and intervals, we excluded
ECGs with the following ﬁndings that were not suitable for
measurement of the ST-segment: rhythms different from
sinus- or ectopic atrial rhythms, bradyarrhythmias (heart rate
<40 beats per minute [bpm]), tachyarrhythmias (heart rate
>110 bpm), ventricular rhythms, delta waves, second- and
third-degree AV-blocks, bundle branch blocks, multiple
premature ventricular complexes, multiple premature atrial
complexes, junctional rhythms, pace spikes, and ST-segment
deviations from the isoelectric line below the 0.005th
percentile and above the 99.995th percentile.
The 12SL algorithm measures ST-segment deviation by
constructing a representative median beat from all PQRST
complexes of the 10-second ECG tracing in the particular
lead. The median complex is shifted so that the voltage at the
QRS onset is 0 by deﬁnition (isoelectric line). The point
measured on the ST-segment is deﬁned as the ST-level at the
QRS offset plus 1/16 of the average RR interval (denoted as
“STM” in the 12SL algorithm). This point is in most cases
equivalent to 80 ms after the J-point, which by convention is
the point used for measuring ST-depression. We chose this
point of measurement for ST-elevation, as our interest was
not the notched or slurred appearance of the terminal part of
the QRS complex, which some denote early repolarization and
which makes deﬁnition of a J-point difﬁcult. Additionally, we
only categorized deviations as elevations if the end of the ST-
segment was higher or equal to the mid-section, and for
ST-depressions only if the end was lower or equal to the mid-
section. This was done to avoid descending ST-elevations and
ascending ST-depressions, as these speciﬁc types of electro-
cardiographic ST-deviations were not the focus of the study.
To evaluate the agreement between the 12SL algorithm
and manual ST-segment measurement, a number of ECGs
(N=200) were sampled for manual evaluation with 100 ECG’s
for evaluation in lead V3 and 100 ECG’s for evaluation in lead
V6. To be able to explore the validity of the automated
measurements also at the extremes of ST-segment devia-
tions, ECGs were randomly sampled from each category of ST-
deviation (see Statistical Analysis). For all manually assessed
ECGs, ST-segments were measured manually in lead V3 for
ST-elevations and lead V6 for ST-depressions at 910
magniﬁcation and with the use of a digital caliper (MUSE
Cardiology Information System, GE Healthcare). The manual
rater (P.V.R.) was blinded to results from the 12SL algorithm.
To evaluate agreement between manual and 12SL measured
ST-segments, results were summarized in a Bland-Altman
plot. Mean differences between manual and 12SL algorithm
measurements were calculated together with the limits of
agreement (2 standard deviations).
Baseline Variables and Follow-Up
Using Danish administrative registries and a unique personal
identiﬁcation number assigned to all persons with permanent
residence in Denmark, it is possible to follow individuals with
respect to death, emigration, the use of prescription drugs,
and any hospital, ambulatory, or emergency room discharge
diagnoses. With the use of such registry data, we identiﬁed
baseline variables concerning comorbidity and medication
status as described previously.12
We deﬁned a modiﬁed version of the Charlson Comorbidity
Index in which we excluded the major cardiovascular ICD-10
codes, as these covariates were adjusted for separately. Using
the modiﬁed Charlson co-morbidity index, we were able to take
several comorbidities including diabetes, various cancer
diseases, liver diseases, and vascular diseases into account.13
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Death from cardiovascular causes (ICD-10: I00-I99) was
the endpoint of interest with supplementary analyses of
all-cause mortality.
Statistical Analysis
Age was used as time-scale in all survival analyses. Follow-
up started at the day of ﬁrst ECG recording (index ECG) and
ended in case of death, emigration, or on December 31,
2011 which was the end of follow-up. Cox regression was
used to assess the association of ST-segment deviation,
measured on the day of inclusion (index ECG), with the
instantaneous risk (hazard) of CVD and all-cause mortality.
All Cox models were adjusted for the following covariates
obtained at baseline: prior treatment with non-loop diuretics,
calcium antagonists, angiotensin-converting enzyme inhibi-
tors, beta blockers, history of heart failure, history of valvular
heart disease, a modiﬁed Charlson comorbidity index,
R-wave amplitude, S-wave amplitude, QRS duration, and
heart rate.
We performed the analysis based on categorization of the
ST-segment deviation in groups of 50 lV with reference to a
nondeviating ST-segment (50 lV to +50 lV). We chose this
range of ST-deviation for our reference group, as we believe
50 lV, corresponding to half of one small square on the
standard ECG, is a credible threshold for what amplitude of
deviations from the isoelectric line is actually possible to
measure on an ECG. Furthermore, this range provided a
reference group of sufﬁcient size.
In addition to the categorical analysis, the relationship
between ST-segment deviations and the risk of CVD was
assessed with the use of restricted cubic regression splines
based on Cox regression models adjusted for the same
covariates as in the categorical analyses.
A subgroup analysis was performed in which we excluded
individuals being hospitalized with myocardial infarction
within 14 days after inclusion.
Poisson regression was used to compare rates of CVD per
1000 person-years in the ECG study population with the
sample from the general population.
We considered a 2-tailed P-value below 0.05 as statistically
signiﬁcant. Proportional hazard assumptions were checked
using log-log survival plots and intersecting curves were
observed for ST-deviations corresponding to 65 years of
age, in particular with respect to lead V6. Accordingly, to
avoid violation of the proportional hazard assumption, analy-
ses were done separately for persons younger and older than
65 years of age. Tests for interaction between gender and ST-
deviations, within the 2 age groups, were performed by
introducing interaction terms to Cox models and by compar-
ing models applying likelihood ratio tests. These tests
indicated statistical signiﬁcant interactions for all leads
(P<0.0001). Consequently, we made separate analyses for
women and men older and younger than 65 years of age,
respectively. In order to test whether ST-changes in lead V1
and V5/V6 were reﬂections of each other, we analyzed the
degree of correlation between ST-deviations in the precordial
leads.
All analyses were conducted using the Stata 12.0 software
package (StataCorp LP).
Results
A total of 343 639 individuals had one or more ECGs
recorded at CGPL during the period from 2001 to 2011. Of
these, 285 194 were eligible for inclusion. Baseline charac-
teristics of the study population are shown in Table 1.
Spectrum and Prevalences of ST-Segment
Deviations
We observed distinct differences between the genders and
age groups in the prevalences of ST-segment deviations
(Figure 1). ST-depressions were generally prevalent in the
lateral and mid-precordial leads and almost non-existent in
the right precordial leads. Additionally, the prevalences of ST-
depression were much higher in the population ≥65 years of
age compared with those ≤65 years of age and almost equally
distributed between the genders.
ST-segment elevations were generally more prevalent
among men compared with women, especially in the
subgroup <65 years of age. As such, we observed that
almost 91% of young men had some degree of ST-elevation in
lead V2 and 45% had ST-elevations ≥150 lV.
In male subjects ≥65 years of age, 17% had ST-elevations
≥150 lV in lead V2, whereas this proportion was 7% for
females.
In lead V3, 38% of the young men and 13% of the older men
had elevations ≥150 lV. The same types of elevations were
observed with a prevalence of 4% in both age categories of
women.
Minor lateral ST-elevation was present, especially among
the young men, but these were not nearly as prevalent as in
V2 through V4 (Figure 1).
Risk of CVD Associated With ST-Segment
Deviations
The median follow-up period for the ECG study population was
5.8 years (interquartile range [IQR] 3.1 to 8.6), corresponding
to 1651 219 person-years. During follow-up, we identiﬁed
6679 cardiovascular deaths and 22 578 deaths from noncar-
diovascular causes.
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ST-depressions and the risk of CVD
In general, increasing ST-segment depression was associated
with a dose-response increase in the risk of CVD for all 4
gender and age determined subgroups (Figure 2).
This association existed for all precordial leads, where ST-
depressions were prevalent (ie, mid-precordial and lateral
leads). This is illustrated by the group of men ≥65 years of
age, where increasing depression in lead V5 was associated
with a HR of 1.59 (95% conﬁdence interval [CI] 1.37 to 1.85,
P<0.0001), 2.27 (95% CI 1.74 to 2.97, P<0.0001), and 3.99
(95% CI 2.69 to 5.92, P<0.0001) for depressions in the range
of ≥50 to <100 lV, ≥100 to <150 lV, and ≥150 lV,
respectively, when compared with a nondeviating ST-segment
(50 lV to +50 lV).
ST-elevations and the risk of CVD
The association between ST-segment elevations and the risk
of CVD was generally much more heterogenic compared
Table 1. Baseline Characteristics of the Study Population
Characteristics
Total (n=285
194)
Women Men
All
(n=160 879)
Age <65
(n=115 651)
Age ≥65
(n=45 097)
All
(n=124 315)
Age <65
(n=100 616)
Age ≥65
(n=23 699)
Age—y, median
(IQR)
53 (41 to 65) 54 (40 to 67) 47 (36 to 56) 75 (70 to 81) 54 (40 to 62) 47 (37 to 56) 72 (68 to 78)
Medical history—no. (%)
Congestive heart
failure
1113 (0.4) 742 (0.5) 131 (0.1) 611 (1) 371 (0.3) 112 (0.1) 259 (1)
Valvular heart
disease
702 (0.2) 426 (0.3) 166 (0.1) 260 (0.6) 276 (0.2) 150 (0.2) 126 (1)
Modified Charlson co-morbidity index
0 points 236 699 (83) 131 413 (80) 100 603 (87) 30 810 (68) 105 286 (85) 88 962 (88) 16 324 (69)
1 point 27 705 (10) 16 408 (10) 9314 (8) 7094 (16) 11 297 (9) 7682 (8) 3615 (15)
≥2 points 20 790 (7) 13 058 (8) 5865 (5) 7193 (16) 7732 (6) 3972 (4) 3760 (16)
Medication history—no. (%)
ACE inhibitors 34 610 (12) 20 168 (13) 9465 (8) 10 703 (24) 14 442 (12) 9122 (9) 5320 (23)
Beta-blockers 34 489 (12) 23 571 (15) 14 526 (13) 9045 (20) 10 918 (9) 7490 (7) 3428 (14)
Calcium-
antagonists
27 946 (10) 16 951 (11) 6999 (6) 9952 (22) 10 995 (9) 6435 (6) 4542 (19)
Non-loop diuretics 59 466 (21) 42 967 (27) 21 029 (18) 21 938 (48) 16 499 (13) 9067 (9) 7432 (31)
ECG variables
Heart rate—bpm,
median (IQR)
69 (62 to 78) 71 (63 to 79) 70 (62 to 78) 73 (65 to 82) 67 (60 to 77) 67 (59 to 76) 69 (61 to 80)
Left ventricular
hypertrophy—
no. (%)
12 286 (4) 3509 (2) 1737 (2) 1772 (4) 8777 (7) 7371 (7) 1406 (6)
QRS duration—
ms, median
(IQR)
92 (86 to 100) 88 (82 to 94) 88 (84 to 94) 88 (82 to 94) 98 (90 to 104) 98 (92 to 104) 96 (88 to
102)
Subjects in ECG reference range (50 to +50 lV)—no. (%)
V1 196 654 (69) 122 242 (76) 90 909 (79) 31 333 (70) 74 412 (60) 59 524 (59) 14 888 (63)
V2 68 332 (24) 52 482 (33) 32 994 (29) 19 488 (43) 15 850 (13) 9433 (9) 6417 (28)
V3 105 227 (37) 83 130 (52) 57 143 (49) 25 987 (58) 22 097 (18) 13 614 (14) 8483 (36)
V4 178 139 (63) 130 603 (81) 93 539 (81) 37 064 (83) 47 536 (38) 32 780 (33) 14 756 (67)
V5 224 851 (79) 146 434 (91) 106 387 (92) 40 047 (89) 78 417 (63) 59 442 (59) 18 975 (81)
V6 254 266 (89) 152 797 (95) 111 296 (96) 41 501 (92) 101 469 (82) 80 563 (80) 20 906 (89)
bpm indicates beats per minute; IQR, inter-quartile range; ms, milliseconds.
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34.2%
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0.32%
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female
male
female
male
> +150μV
+100μV to +150μV
+50μV to +100μV
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-100μV to -150μV
< -150μV
> +150μV
+100 to +150μV
+50μV to +100μV
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+100μV to +150μV
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< -150μV
> +150μV
+100μV to +150μV
  +50μV to +100μV
  -50μV to -100μV
-100μV to -150μV
< -150μV
Voltage categories
Individuals (>65 years)
Voltage categories
female
male
0.00%
0.00%
0.05%
19.3%
1.79%
0.23%
0 %
0.01%
0.22%
30.3%
8.06%
0.20%
female
male
0.02%
0.04%
1.09%
15.7%
1.94%
0.30%
0.04%
0.07%
0.55%
33.6%
19.9%
13.0%
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-100μV to -150μV
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V4
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Voltage categories
0%
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22.1%
9.09%
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0.01%
0.05%
20.5%
24.7%
45.3%
0.02%
0.07%
1.59%
6.01%
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0.08%
0.15%
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7.69%
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V5
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0.01%
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34.2%
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0.14%
23.9%
24.5%
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1.38%
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0.05%
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0.17%
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A
B Individuals (<65 years)
Figure 1. Bar charts displaying the prevalences and distribution of precordial ST-segment deviations in the
different voltage categories of (≥50 to<100 lV, ≥100 to<150 lV and ≥150 lV) in the subgroup ofmen and
women younger and older than 65 years of age. Orange bars represent ST-elevations and blue bars
represent ST-depressions. It is supposed to be A, Old (≥65 years), B, Young (<65 years).
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 Voltage 
Men (>65 years)
 categories HR (95 % CI) HR (95 % CI) HR (95 % CI)
3V2V1V
)71.1-48.0( 99.0)81.1-68.0( 10.1)60.3-68.1( 93.2Vμ 051+ >
)59.0-27.0( 38.0)30.1-87.0( 98.0)09.1-73.1( 16.1Vμ 051+ ot 001+
)10.1-08.0( 09.0)49.0-47.0( 48.0)63.1-01.1( 22.1Vμ 001+ ot 05+ 
]ecnerefeR[ 00.1]ecnerefeR[ 00.1]ecnerefeR[ 00.1Vμ  05+ ot 05-
)22.2-60.1( 35.1)11.3-88.0( 66.1)89.3-80.0( 65.0Vμ 001- ot 05-
)98.4-79.0( 81.2)14.91-79.1( 81.6]dettimO[Vμ 051- ot 001-
)21.03-68.1( 84.7]dettimO[]dettimO[Vμ 051- <
6V5V4V
]dettimO[]dettimO[)00.1-24.0( 56.0Vμ 051+ >
+100 to +150 μV ]dettimO[]dettimO[)99.0-56.0( 08.0
)09.0-24.0( 26.0)09.0-16.0( 47.0)39.0-37.0( 28.0Vμ 001+ ot 05+ 
]ecnerefeR[ 00.1]ecnerefeR[ 00.1]ecnerefeR[ 00.1Vμ  05+ ot 05-
)28.1-53.1( 75.1)58.1-73.1( 95.1)90.2-64.1( 47.1Vμ 001- ot 05-
)43.4-05.2( 03.3)79.2-47.1( 72.2)78.2-03.1( 29.1Vμ 051- ot 001-
)88.5-21.2( 35.3)29.5-96.2( 99.3)57.3-11.1( 40.2Vμ 051- <
  0.5    1      2.5  5   10  20 30   0.5    1      2.5    5    10  20 30   0.5    1     2.5    5     10  20 30
*
*
*
*
*
*
*
 Voltage 
 categories HR (95 % CI) HR (95 % CI) HR (95 % CI)
3V2V1V
)86.0-24.0( 35.0)09.0-55.0( 07.0)10.3-52.1( 49.1Vμ 051+ >
)37.0-84.0( 95.0)57.0-74.0( 95.0)53.2-54.1( 58.1Vμ 051+ ot 001+
)67.0-15.0( 26.0)39.0-16.0( 57.0)02.1-58.0( 10.1Vμ 001+ ot 05+ 
]ecnerefeR[ 00.1]ecnerefeR[ 00.1]ecnerefeR[ 00.1Vμ  05+ ot 05-
)93.3-64.0( 52.1]dettimO[)84.01-80.1( 63.3Vμ 001- ot 05-
)25.23-46.0( 55.4]dettimO[]dettimO[Vμ 051- ot 001-
]dettimO[]dettimO[]dettimO[Vμ 051- <
6V5V4V
]dettimO[]dettimO[)61.1.85.0( 38.0Vμ 051+ >
+100 to +150 μV )82.3-46.0( 54.1)10-1-03.0( 26.0)98.0-55.0( 07.0
)59.0-25.0( 07.0)49.0-36.0( 77.0)98.0-36.0( 57.0Vμ 001+ ot 05+ 
]ecnerefeR[ 00.1]ecnerefeR[ 00.1]ecnerefeR[ 00.1Vμ  05+ ot 05-
)20.4-52.2( 10.3)81.4-23.2( 21.3)02.3-02.1( 69.1Vμ 001- ot 05-
)45.01-40.3( 66.5)02.7-24.1( 02.3)11.7-44.0( 67.1Vμ 051- ot 001-
)08.41-88.0( 16.3)77.41-61.3( 48.6)86.81-45.2( 09.6Vμ 051- <
*
*
  0.5    1      2.5  5   10  20 30   0.5    1      2.5    5    10  20 30   0.5    1     2.5    5     10  20 30
*
*
*
*
*
*
A
B Men (<65 years)
Figure 2. Associations of ST-segment deviation and cardiovascular death. Forest plots depicting multivariable-adjusted hazard ratios for
cardiovascular death by voltage categories (≥50 to 100> lV, ≥100 to 150> lV and ≥150 lV) with reference to an isoelectric ST-segment. All
models were adjusted for heart failure, valvular heart disease, Charlson comorbidity index (0 points, 1 point, or ≥2 points), treatment with
angiotensin converting enzyme (ACE)-inhibitors, beta-blockers, or calcium-antagonists prior to inclusion, digoxin at the day of ECG recording, R-
wave and S-wave amplitude on the index ECG, and age was the timescale. The horizontal solid lines represent 95% conﬁdence intervals and vertical
lines represent a HR of 1. A, Men, old (≥65 years); (B) Men, young (<65 years); (C) Women, old (≥65 years); (D) Women, young (<65 years).
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with ST-segment depressions. We found that elevations in
lead V1 conferred an increased risk of CVD for both genders
and age groups (Figure 2) and thus, within our subgroup of
young men, we found elevations in V1 to be associated with
a highly signiﬁcant increased risk of CVD as evidenced by an
HR of 1.85 (95% CI 1.45 to 2.35, P<0.001) for elevations
between 100 to 150 lV and an HR of 1.94 (95% CI 1.25 to
3.01, P=0.005) for elevations ≥150 lV compared with a
 Voltage 
Women (>65 years)
 categories HR (95 % CI) HR (95 % CI) HR (95 % CI)
3V2V1V
)75.1-51.1( 43.1)85.1-32.1( 93.1)08.2-88.1( 92.2Vμ 051+ >
)33.1-60.1( 91.1)02.1-89.0( 80.1)39.1-15.1( 17.1Vμ 051+ ot 001+
)60.1-09.0( 89.0)30.1-78.0( 59.0)92.1-11.1( 02.1Vμ 001+ ot 05+ 
]ecnerefeR[ 00.1]ecnerefeR[ 00.1]ecnerefeR[ 00.1Vμ  05+ ot 05-
)22.2-73.1( 57.1)82.2-30.1( 35.1)43.3-28.0( 66.1Vμ 001- ot 05-
)05.4-06.1( 86.2)97.4-90.0( 76.0]dettimO[Vμ 051- ot 001-
)07.4.18.0( 59.1]dettimO[]dettimO[Vμ 051- <
6V5V4V
]dettimO[)11.9-49.0( 29.2)66.2-13.1( 68.1Vμ 051+ >
+100 to +150 μV )24.8-81.1( 51.3)05.2-27.0( 43.1)89.1-33.1( 26.1
)25.1-87.0( 90.1)46.1-51.1( 73.1)21.1-09.0( 10.1Vμ 001+ ot 05+ 
]ecnerefeR[ 00.1]ecnerefeR[ 00.1]ecnerefeR[ 00.1Vμ  05+ ot 05-
)97.1-24.1( 06.1)16.1-82.1( 44.1)06.1-12.1( 93.1Vμ 001- ot 05-
)90.3-59.1( 64.2)23.3-12.2( 17.2)38.2-46.1( 61.2Vμ 051- ot 001-
)61.5-15.2( 06.3)67.3-49.1( 07.2)77.4-99.1( 80.3Vμ 051- <
  0.5    1      2.5  5   10  20 30   0.5    1      2.5    5    10  20 30   0.5    1     2.5    5     10  20 30
*
* *
*
 Voltage 
 categories HR (95 % CI) HR (95 % CI) HR (95 % CI)
3V2V1V
)84.2-09.0( 05.1)25.1-16.0( 69.0)62.9-91.1( 23.3Vμ 051+ >
)65.1-67.0( 90.1)81.1-26.0( 58.0)26.3-33.1( 91.2Vμ 051+ ot 001+
)62.1-87.0( 99.0)70.1-66.0( 48.0)37.1-70.1( 63.1Vμ 001+ ot 05+ 
]ecnerefeR[ 00.1]ecnerefeR[ 00.1]ecnerefeR[ 00.1Vμ  05+ ot 05-
)89.5-61.1( 36.2)06.11-07.0( 58.2)39.92-75.0( 51.4Vμ 001- ot 05-
)04.13-81.4( 64.11]dettimO[]dettimO[Vμ 051- ot 001-
)4.853-56.5( 99.44]dettimO[]dettimO[Vμ 051- <
6V5V4V
]dettimO[]dettimO[)99.7-39.0( 27.2Vμ 051+ >
+100 to +150 μV ]dettimO[]dettimO[)33.3-69.0( 87.1
)91.4-10.1( 60.2)43.2-39.0( 84.1)63.1-27.0( 99.0Vμ 001+ ot 05+ 
]ecnerefeR[ 00.1]ecnerefeR[ 00.1]ecnerefeR[ 00.1Vμ  05+ ot 05-
)07.2-80.1( 17.1)23.2-49.0( 84.1)66.2-68.0( 15.1Vμ 001- ot 05-
)29.61-41.2( 20.6)54.61-16.1( 31.5)51.81-90.1( 54.4Vμ 051- ot 001-
)9.041-16.8( 08.43)69.14-19.3( 18.21)92.04-17.3( 12.21Vμ 051- <
  0.5    1      2.5  5   10  20 30   0.5    1    2.5  5   10  20 30   0.5    1     2.5    5   10  20 30
*
*
*
*
*
*
*
*
C
D Women (<65 years)
Figure 2. (Continued).
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nondeviating ST-segment (50 lV to +50 lV). This
association was the least strong in the group of young
women.
We found ST-elevations in V2 to be associated with a
modest increased risk of CVD only in older women. This was
in contrast to young men where we observed a decreased risk
for the same elevations with an HR of 0.59 (95% CI 0.47 to
0.75, P<0.0001) for having elevations between 100 to
150 lV.
The same pattern of association was found for ST-
elevations in V3. In the subgroup of young men, we observed
a decreased risk associated with ST-elevations, similar to
those observed for lead V2, with HRs of 0.59 (95% CI 0.48 to
0.73, P=0.002) and 0.53 (95% CI 0.42 to 0.68, P=0.008) for
CVD with respect to elevations in the range 100 to 150 lV
and ≥150 lV, respectively. This is in contrast to young
women, where the same elevations conferred HRs of 1.09
(95% CI 0.76 to 1.56, P=0.109) and 1.50 (95% CI 0.90 to
2.48, P=0.003), respectively.
ST-elevations in lead V4 were associated with an increased
risk of CVD in both young and old women, with the strongest
effect seen in young women where elevations ≥150 lV were
associated with an HR of 2.72 (95% CI 0.93 to 7.99, P=0.069)
for CVD compared with a nondeviating ST-segment (Figure 2).
There was no signiﬁcant association among men, albeit with a
slight indication of a decreased risk of CVD for both age groups
in lead V4.
Lateral ST-elevations in V5 to V6 seemed to be associated
with an increased risk of CVD, but the relatively few endpoints
made any conclusions impossible.
Representative examples of the described ST-segment
deviations taken from the population are provided in
Figure 3.
ST-deviations and the risk of all-cause mortality
Results for all-cause mortality in general revealed results
similar to those for CVD but with attenuated effects and
narrower conﬁdence limits due to the larger number of
endpoints (see Figure 4).
Additional Results
Electrocardiographic validations
We performed a validation analysis and found good agree-
ment between manual and 12SL automated ST-segment
measurement (see Figure 5). For comparison of automated
ST-segment measuring of ST-elevation in lead V3 with
manual measurement we found a mean difference of
16.66 lV (95% CI 22.41 to 10.91 lV) with limits of
agreement (2 standard deviations) between 74.6 to
41.3 lV.
Automated ST-segment depression in lead V6 compared
with manual measurement showed a mean difference of
5.545 lV (95% CI 11.07 to 0.02) with limits of agreement
between 74.64 to 41.320 lV.
Comparison to controls sampled from the general
population
The incidence rate of CVD was 4.05 (95% CI 3.96 to 4.16) per
1000 person-years in the ECG study population compared
with 3.78 (95% CI 3.71 to 3.84) in the sampled control
population (matched 1:2 based on gender and age at the time
of inclusion, P<0.001).
Sensitivity analysis
We analyzed a subgroup in which we excluded individuals
being hospitalized with ischemic heart disease within
14 days after inclusion (N=1264 or 0.4%) and found that
the patterns of association did not change (data not
shown).
V1
V2
V3
V4
V5
V6
A B C D
Figure 3. Representative examples of the precordial leads of
ECG’s emphasized in the text. A, Older man with lateral ST-
depression in V5/V6; (B) Younger man with ST-elevation in V1; (C)
Younger man with ST-elevation in V2/V3; (D) Younger woman with
ST-elevation in V4.
DOI: 10.1161/JAHA.113.000549 Journal of the American Heart Association 8
ST-Segment Deviations and Death Rasmussen et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on February 7, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
Correlation analysis
We found a certain degree of correlation between adjacent
leads with the strongest correlation seen between lead V5 and
V6 (R2=0.909). We found no noteworthy inverse correlation
between ST-elevations in V1 and ST-depressions in lead V5 and
lead V6 (R2=0.03 and R2=0.15, respectively). See Table 2.
 Voltage 
Men (>65 years)
 categories HR (95 % CI) HR (95 % CI) HR (95 % CI)
3V2V1V
)89.0-38.0( 09.0)19.0-77.0( 38.0)16.1-92.1( 93.1Vμ 051+ >
)49.0-28.0( 88.0)78.0-67.0( 28.0)82.1-70.1( 71.1Vμ 051+ ot 001+
)89.0-88.0( 39.0)29.0-28.0( 78.0)80.1-79.0( 20.1Vμ 001+ ot 05+ 
]ecnerefeR[ 00.1]ecnerefeR[ 00.1]ecnerefeR[ 00.1Vμ  05+ ot 05-
)36.1-11.1( 53.1)25.2-34.1( 19.1)40.3-13.1( 00.2Vμ 001- ot 05-
)89.2-33.1( 99.1)77.5-55.1( 99.2)59.21-62.0( 28.1Vμ 051- ot 001-
)82.6-24.1( 99.2]dettimO[]dettimO[Vμ 051- <
6V5V4V
)52.51-03.0( 51.2)77.1-15.0( 59.0)69.0-66.0( 08.0Vμ 051+ >
+100 to +150 μV )67.1-04.0( 48.0)52.1-67.0( 89.0)89.0-08.0( 88.0
)98.0-56.0( 67.0)69.0-18.0( 88.0)89.0-88.0( 39.0Vμ 001+ ot 05+ 
]ecnerefeR[ 00.1]ecnerefeR[ 00.1]ecnerefeR[ 00.1Vμ  05+ ot 05-
)13.1-11.1( 12.1)82.1-90.1( 91.1)43.1-90.1( 12.1Vμ 001- ot 05-
)53.2-76.1( 89.1)28.1-33.1( 55.1)88.1-12.1( 15.1Vμ 051- ot 001-
)88.2-55.1( 11.2)66.2-16.1( 70.2)42.2-61.1( 16.1Vμ 051- <
  0.5    1      2.5  5   10  20 30   0.5    1      2.5    5    10  20 30   0.5    1     2.5    5     10  20 30
* *
 Voltage 
 categories HR (95 % CI) HR (95 % CI) HR (95 % CI)
3V2V1V
)67.0-26.0( 96.0)66.0-35.0( 95.0)68.1-32.1( 15.1Vμ 051+ >
)28.0-96.0( 57.0)96.0-75.0( 26.0)03.1-30.1( 61.1Vμ 051+ ot 001+
)88.0-57.0( 28.0)38.0-96.0( 67.0)80.1-49.0( 10.1Vμ 001+ ot 05+ 
]ecnerefeR[ 00.1]ecnerefeR[ 00.1]ecnerefeR[ 00.1Vμ  05+ ot 05-
)89.1-98.0( 33.1)14.1-02.0( 35.0)22.3-80.1( 78.1Vμ 001- ot 05-
)11.4-80.0( 85.0)47.9-91.0( 73.1]dettimO[Vμ 051- ot 001-
)93.5-11.0( 67.0)14.89-49.1( 08.31]dettimO[Vμ 051- <
6V5V4V
)58.4-11.0( 86.0)34.1-06.0( 39.0)99.0-47.0( 68.0Vμ 051+ >
+100 to +150 μV )06.1-17.0( 70.1)60.1-47.0( 98.0)49.0-77.0( 58.0
)50.1-38.0( 39.0)29.0-87.0( 58.0)49.0-28.0( 88.0Vμ 001+ ot 05+ 
]ecnerefeR[ 00.1]ecnerefeR[ 00.1]ecnerefeR[ 00.1Vμ  05+ ot 05-
)47.1-62.1( 84.1)86.1-12.1( 24.1)00.2-03.1( 26.1Vμ 001- ot 05-
)21.4-10.2( 88.2)01.3-83.1( 70.2)18.2-18.0( 15.1Vμ 051- ot 001-
)25.6-68.1( 84.3)67.4-18.1( 49.2)30.4-19.0( 19.1Vμ 051- <
  0.5    1      2.5  5   10  20 30   0.5    1      2.5    5    10  20 30   0.5    1     2.5    5     10  20 30
*
*
A
B Men (<65 years)
Figure 4. Forest plots showing the association between ST-segment deviations and all-cause mortality demonstrating the same associations
as the main analyses with regard to cardiovascular death (CVD) but with attenuated effect. A, Men, old (≥65 years); (B) Men, young
(<65 years); (C) Women, old (≥65 years); (D) Women, young (<65 years).
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Median voltages
The median voltages in each precordial lead for both age and
gender groups are summarized in Table 3.
Restricted cubic spline analyses
The restricted cubic regression spline analyses were in
concordance with the categorical analysis regarding the
 Voltage 
 categories HR (95 % CI) HR (95 % CI) HR (95 % CI)
3V2V1V
)34.1-69.0( 71.1)79.0-96.0( 28.0)18.3-86.1( 35.2Vμ 051+ >
)22.1-49.0( 70.1)59.0-67.0( 58.0)55.1-10.1( 52.1Vμ 051+ ot 001+
)90.1-29.0( 10.1)49.0-97.0( 78.0)41.1-59.0( 40.1Vμ 001+ ot 05+ 
]ecnerefeR[ 00.1]ecnerefeR[ 00.1]ecnerefeR[ 00.1Vμ  05+ ot 05-
)95.2-22.1( 87.1)50.5-78.1( 70.3)32.4-44.0( 63.1Vμ 001- ot 05-
)82.6-80.1( 06.2)35.66-03.1( 13.9]dettimO[Vμ 051- ot 001-
)39.55-44.3( 78.31)04-18-20.5( 22.02]dettimO[Vμ 051- <
6V5V4V
]dettimO[]dettimO[)79.2-40.1( 67.1Vμ 051+ >
+100 to +150 μV ]dettimO[]dettimO[)08.1-60.1( 83.1
)58.1-30.1( 83.1)86.1-12.1( 24.1)73.1-11.1( 42.1Vμ 001+ ot 05+ 
]ecnerefeR[ 00.1]ecnerefeR[ 00.1]ecnerefeR[ 00.1Vμ  05+ ot 05-
)37.1-71.1( 34.1)75.1-90.1( 13.176.1-70.1( 33.1Vμ 001- ot 05-
)24.6-30.2( 16.3)53.6-20.2( 85.3)08.1-60.1( 83.1Vμ 051- ot 001-
)41.12-91.2( 18.691.01-47.1( 12.4)66.8-84.1( 85.3Vμ 051- <
  0.5    1      2.5  5   10  20 30   0.5    1      2.5    5    10  20 30   0.5    1     2.5    5     10  20 30
*
*
*
* *
*
D
 Voltage 
Women (>65 years)
 categories HR (95 % CI) HR (95 % CI) HR (95 % CI)
3V2V1V
)05.1-82.1( 93.1)02.1-50.1( 21.1)67.1-83.1( 65.1Vμ 051+ >
)62.1-21.1( 91.1)10.1-19.0( 59.0)63.1-81.1( 62.1Vμ 051+ ot 001+
)60.1-89.0( 20.1)69.9-09.0( 39.0)50.1-79.0( 10.1Vμ 001+ ot 05+ 
]ecnerefeR[ 00.1]ecnerefeR[ 00.1]ecnerefeR[ 00.1Vμ  05+ ot 05-
)64.1-01.1( 72.1)47.1-51.1( 14.1)20.2-39.0( 73.1Vμ 001- ot 05-
)13.2-80.1( 55.1)64.3-00.1( 68.1)20.9-65.0( 52.2Vμ 051- ot 001-
)23.3-43.1( 11.2)74.7-92.1( 01.3]dettimO[Vμ 051- <
6V5V4V
)66.21-87.1( 47.4)86.5-46.1( 50.3)81.2-64.1( 97.1Vμ 051+ >
+100 to +150 μV )20.4-61.1( 71.2)52.2-52.1( 86.1)96.1-63.1( 25.1
)64.1-60.1( 42.1)75.1-23.1( 44.1)32.1-90.1( 71.1Vμ 001+ ot 05+ 
]ecnerefeR[ 00.1]ecnerefeR[ 00.1]ecnerefeR[ 00.1Vμ  05+ ot 05-
)23.1-61.1( 42.1)32.1-80-1( 51.1)32.1-11.1( 61.1Vμ 001- ot 05-
)50.2-55.1( 87.1)29.1-84.1( 86.1)38.1-13.1( 55.1Vμ 051- ot 001-
)05.2-94.1( 39.1)92.2-25.1( 78.1)69.2-67.1( 82.2Vμ 051- <
  0.5    1      2.5  5   10  20 30   0.5    1      2.5    5    10  20 30   0.5    1     2.5    5     10  20 30
*
C
Women (<65 years)
Figure 4. (Continued)
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relationship between ST-segment deviations and the risk of
CVD (see Figure 6).
Discussion
In a large primary care population without a history ischemic
heart disease, we examined the spectrum and prevalence of
precordial ST-segment deviations and investigated the asso-
ciation with CVD. This revealed signiﬁcant differences across
age and gender determined subgroups.
We observed the highest prevalence of ST-depressions in
the lateral leads and found that the population ≥65 years had
a much higher prevalence of depressions compared with the
younger population. This is in accordance with the primary
etiology for ST-depression probably being ischemia or strain
due to increased left ventricular workload. We found no
notable differences in the occurrence of ST-depression
between genders.
The largest relative risk of CVD associated with ST-
depression was seen among the women and the young,
although, as a result of low prevalences of ST-depressions and
outcomes in these groups, conﬁdence interval limits were wide.
However, when focusing on leads with higher prevalences of
ST-depression we found that ST-segment depressions in leads
V4 to V6 were associated with an increased risk of CVD in a
dose-response manner as seen in Figure 2. Our sample size
and detailed measurement data allowed us to obtain informa-
tion of prevalences and prognosis associated with various
degrees of ST-depression in individual precordial leads. As a
result of this, we could identify leads V5 and V6 as those leads
where the most robust association, with narrowest conﬁdence
limits, between ST-depression and CVD is found.
A widely used method of categorizing ECG abnormalities is
by Minnesota Coding, which contains codes for varying
degrees of ST-depression in groups of leads. However, these
categories are often grouped into minor or major ST-T
abnormalities in order to obtain sufﬁcient statistical power.14
Hence, previous studies have not been able to show
convincing dose response associations or have not been able
to report in what electrocardiographic lead that the statistical
association was most robust.
Our ﬁndings regarding ST-depressions are generally in line
with other publications concerning ST-depression being a
marker of severe cardiovascular morbidity.1–3 The prognostic
value of this was emphasized by De Bacquer et al, who
showed that ST-depression on the baseline ECG was the
electrocardiographic abnormality, among several ECG ﬁnd-
ings, that showed the strongest predictive power of CVD.15
Data on prevalence and associated outcomes of ST-
segment elevations is a more complex matter, probably
-1
00
-5
0
0
50
-50 0 50 100 150 200 250 300 350 400
Average manual and 12SL
      ST-segment estimation(µV)
-1
00
-5
0
0
50
10
0
100500-50-100-150-200-250-300
Average manual and 12SL
      ST-segment estimation(µV)
+2 SD
-2 SD
+2 SD
-2 SD
Figure 5. Agreement between automated ST-segment measure-
ments (Marquett 12SL algorithm) and manual measurements.
Bland-Altman plot for ST-elevation (top) and ST-depression (bot-
tom). SD, standard deviation.
Table 2. Correlation Coefﬁcients (R2) Illustrating the Degree of Correlation Between the Different Electrocardiographic Leads
Based on the Voltage Categories
V1 V2 V3 V4 V5 V6
V1 1.0000
V2 0.6220 1.0000
V3 0.3782 0.7792 1.0000
V4 0.1601 0.6391 0.8702 1.0000
V5 0.0304 0.4866 0.6731 0.8823 1.0000
V6 0.1513 0.3568 0.5087 0.7312 0.9090 1.0000
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because of mixed etiologies and deﬁnitions. Our ﬁndings
show that 70% among our subgroup of men <65 years of age
had more than 100 lV of ST-elevation in lead V2. In men
≥65 years of age, this proportion was almost halved to a
prevalence of 40%. It is highly probable that the proportion of
subjects with this “male-type” ST-elevation would have been
even higher with a lower age cut-off which is concordant with
previous ﬁndings: In a study of 6014 healthy men aged 16 to
58 years from the United States Air Force, 91% had more
than 100 lV of ST-elevation in one or more of the precordial
leads with V2 as the lead where ST-elevations were most
commonly seen.7 In a more recent study of 529 men between
17 to 24 years of age, 93% had ST-elevations in leads V1
through V4. This prevalence declined with age and only 30% of
the men who were ≥76 years had right precordial ST-
elevations on their resting ECG.8
Our ﬁndings in men are in contrast with the prevalence of
ST-elevation we found among women. We observed a much
lower prevalence of major (>100 lV) ST-elevations in lead V2
to V3 among women, and correspondingly a higher prevalence
of minor elevations. This prevalence was not age dependent
with 40% of the young women and 34% of the older women
having the minor ST-elevation. This “female-type” of ST-
elevation with ST-elevations <100 lV and with the same
prevalence throughout age groups has previously been
described by Surawicz et al.8
The fact that the majority of the young men had >100 lV
ST-elevation in lead V2 and V3 emphasizes a point previously
proposed; that this is not only a normal variant but effectively
the normal pattern of a young male subject, possibly
associated with physical ﬁtness.9
This point is further underlined by our association analyses
in which we observed a decreased risk of cardiovascular
death associated with V2 to V3 ST-elevations in young men.
We believe we are the ﬁrst to show this. However, previous
studies have hinted at this. Accordingly, the electrocardio-
graphic pattern of early repolarization also with an upsloping
ST-segment in inferolateral leads has, in contrast to other
types of early repolarization, been shown not to be associated
with sudden arrhythmic death in a general population.16 In
addition, a recent study of healthy middle-aged males showed
that the same form of ST-elevation during exercise test was
associated with a 30% reduced risk of death from coronary
heart disease.17 Accordingly, having a nondeviating ST-
segment in these leads actually seems to represent a
difference from the benign standard in young males, some-
thing that may signal poor ﬁtness. Unfortunately, we do not
possess data regarding physical ﬁtness on our study popu-
lation.
Also worth noting is that we observed no such decreased
mortality associated with ST-elevations in V2 to V3 among
young women.
We observed a signiﬁcantly increased risk of CVD for
women and men with ST-elevations in V1. However, major
ST-elevations (>100 lV) in lead V1 are generally very
uncommon compared with lead V2 and lead V3 (Figure 1).
The arrythmogenic condition known as Brugada Syndrome is
characterized, among other things, by a characteristic ST-
elevation in V1 and a high risk of sudden cardiac death.18
Whether the causal mechanism underlying our observed
increased risk of CVD for persons with ST-elevations in lead
V1, is caused by pathophysiological mechanisms similar to
those underlying Brugada syndrome is not known.
Nevertheless, major ST-elevations in V1 remain a relatively
rare but ominous harbinger of cardiovascular mortality in
our study population. Furthermore, it is worth noting that
the association, by far, is the least robust among young
women.
We examined if ST-elevations in lead V1 could simply be a
mirror image of lateral ST-depressions and hence explain the
increased risk of CVD seen for lead V1 but this did not seem
to be the case (see Table 2).
J-point elevations in the left precordial leads, as a part of
the early repolarization syndrome, has been associated with
sudden cardiac death and cardiovascular mortality, but is still
subject to some controversy.19–22 Interestingly, a recent
study looking a J-point elevation in any lead showed a
signiﬁcant increase in the risk of sudden cardiac death and
coronary heart disease for women, but not for men.23 This
ﬁnding could be explained by the association in men being
Table 3. Median (IQR) ST-Segment Voltages (lV) for Both Age- and Gender Groups
Men <65 Years Men ≥65 Years Women <65 Years Women ≥65 Years
V1 43 (24 to 73) 39 (19 to 68) 34 (14 to 48) 34 (19 to 58)
V2 141 (87 to 200) 83 (48 to 126) 78 (48 to 107) 58 (29 to 92)
V3 122 (78 to 180) 68 (34 to 112) 53 (24 to 83) 39 (14 to 73)
V4 73 (39 to 117) 29 (0 to 63) 19 (0 to 43) 9 (10 to 34)
V5 39 (14 to 68) 4 (20 to 29) 9 (10 to 24) 5 (25 to 14)
V6 24 (4 to 43) 0 (25 to 14) 4 (10 to 19) 10 (25 to 9)
IQR indicates inter-quartile range.
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Figure 6. Restricted cubic regression splines depicting the association between the ST-segment amplitude and the risk
of CVD based on cox regression models adjusted for the same covariates as the categorical analysis (see Methods). Note
the different axes due to variation between leads. A, Men, old (≥65 years); (B) Men, young (<65 years); (C) Women, old
(≥65 years); (D) Women, young (age <65 years).
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Figure 6. (Continued).
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cancelled out because of the presence of both protective and
harmful ST-elevation in this group and are thus in line with our
ﬁndings.
All ECGs were analyzed digitally with the use of clinically
validated software, thus avoiding any intra- or interobserver
variability. We evaluated the computer-based Marquette 12SL
algorithm with respect to ST-segment measurement against
manual measurement and found a high degree of agreement
(see Results and Figure 5). This is in accordance with previous
ﬁndings that computer-based algorithms are equal, or in fact
superior, to visual measurement in terms of ST-deviation
measurement for the purpose of risk prediction.3,24
We performed restricted cubic regression splines, which
showed similar associations between ST-segment deviations
and CVD as the categorical analyses. This underlines the fact
that our ﬁndings are not affected whether a categorical or
continuous approach is used. It should be noted that the spline
analyses include ascending ST-depressions and descending ST-
elevations contrary to the categorical analyses, indicating that
these speciﬁc types of deviations do not distort our results.
Limitations
Our study cohort accounts for one-third of the population in
the greater region of Copenhagen, the capital of Denmark.
Hence, we believe that our study sample is a fair represen-
tation of the background population. Nevertheless, it is
appropriate to address that the individuals were referred to
ECG recording by their general practitioner for a reason. To
address this issue, we performed supplementary analyses in
which we compared the rate of cardiovascular mortality in the
study population with individuals from the general Danish
population matched on age, gender, and without individuals
with ischemic heart disease at the time of inclusion. We found
a slightly increased CVD rate of 4.05 (95% CI 3.96 to 4.16) per
1000 person-years in the study population compared with
3.78 (95% CI 3.71 to 3.84) in background population
(P<0.001). Although this difference was statistically signiﬁ-
cant it seems negligible, indicating that our study population
is fairly representative of the general population. Additionally
most non-opportunistic cohort studies suffer from the oppo-
site issue with an often-pronounced, healthy responder
bias.25 Accordingly, we believe that our study population is
a fair representation of the general population.
We investigated whether selection bias due to acute
coronary syndrome could be an issue by performing a subgroup
analysis in which we excluded individuals being hospitalized
with ischemic heart disease within 14 days after inclusion. This
did not signiﬁcantly alter our results. Even though this approach
represents some methodological problems with conditioning
on the future, we believe it is justiﬁed in order to exclude a
potential causal link to acute ischemia in our results.
Finally, we lack important anthropometric data on our
study population such as body mass index (BMI), blood
pressure, and smoking status and therefore we cannot
exclude some residual confounding. However, we were able
to adjust for several cardiovascular risk factors that are likely
intermediate phenotypes for the possible confounding effect
of BMI, blood pressure, and smoking status on the association
between ST-segment deviations and the risk of CVD. Instead
of controlling for blood pressure, we were able to adjust for
treatment with antihypertensive medication at inclusion. We
believe that this approach might be as good as controlling for
a single ambulatory blood pressure measurement, as such a
blood pressure is not always a good estimate of an
individual’s true resting blood pressure.26,27
Conclusions
In this study of more than 280 000 primary care patients
without a history of ischemic heart disease, we examined in
detail the association between ST-segment deviations and
risk of CVD and found signiﬁcant age and gender differences
in some of the electrocardiographic leads.
We found ST-depressions to confer an increased risk of
CVD in a dose-response manner in nearly all leads for both
genders and age groups, with the most robust association
seen in leads V5 and V6. ST-elevations in women, in general,
were associated with increased risk of CVD as were elevations
in V1 in men. Among young men, however, we observed a
decreased risk of CVD associated with ST-elevations in V2 and
V3. We believe we are the ﬁrst to show a decreased risk of
CVD with certain ST-elevations. Prognostic information regard-
ing these ST-segment deviations could contribute towards
improving the risk stratiﬁcation of patients.
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